Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
8.68
0.98 (12.73%)
At close: Aug 18, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 18, 2025, 07:00 PM EDT
12.73% (1D)
| Bid | 6.37 |
| Market Cap | 53.39M |
| Revenue (ttm) | 3.17M |
| Net Income (ttm) | -74.18M |
| EPS (ttm) | -13.27 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | -0.85 |
| Analyst | Buy |
| Ask | 10.11 |
| Volume | 72,041 |
| Avg. Volume (20D) | 98,204 |
| Open | 7.89 |
| Previous Close | 7.70 |
| Day's Range | 7.78 - 9.00 |
| 52-Week Range | 3.76 - 46.80 |
| Beta | 2.77 |
About ALGS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ALGS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ALGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Aligos Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
19 hours ago
+13.9%
Aligos Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
5 months ago
-19.55%
Aligos Therapeutics shares are trading lower after the company reported Q4 financial results and missed its EPS estimate.
